Literature DB >> 11831558

Peptides as drugs: is there a market?

Albert Loffet1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11831558     DOI： 10.1002/psc.366

Source DB:  PubMed          Journal:  J Pept Sci        ISSN： 1075-2617            Impact factor:   1.905


× No keyword cloud information.
  32 in total

1.  Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.

Authors:  Robert P Sellers; Leslie D Alexander; Victoria A Johnson; Chun-Chieh Lin; Jeremiah Savage; Ricardo Corral; Jason Moss; Tim S Slugocki; Erinprit K Singh; Melinda R Davis; Suchitra Ravula; Jamie E Spicer; Jenna L Oelrich; Andrea Thornquist; Chung-Mao Pan; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2010-07-22       Impact factor: 3.641

2.  ENPDA: an evolutionary structure-based de novo peptide design algorithm.

Authors:  Ignasi Belda; Sergio Madurga; Xavier Llorà; Marc Martinell; Teresa Tarragó; Mireia G Piqueras; Ernesto Nicolás; Ernest Giralt
Journal:  J Comput Aided Mol Des       Date:  2005-11-03       Impact factor: 3.686

3.  Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.

Authors:  Adam Pepperney; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

4.  Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain.

Authors:  Sara M Hall; Lindsay LeBaron; Cyf Ramos-Colon; Chaoling Qu; Jennifer Yanhua Xie; Frank Porreca; Josephine Lai; Yeon Sun Lee; Victor J Hruby
Journal:  ACS Chem Neurosci       Date:  2016-09-27       Impact factor: 4.418

5.  Proton-detected solid-state NMR spectroscopy of natural-abundance peptide and protein pharmaceuticals.

Authors:  Donghua H Zhou; Gautam Shah; Charles Mullen; Dennis Sandoz; Chad M Rienstra
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

6.  A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines.

Authors:  Po-Shen Pan; Robert C Vasko; Stephanie A Lapera; Victoria A Johnson; Robert P Sellers; Chun-Chieh Lin; Chung-Mao Pan; Melinda R Davis; Veronica C Ardi; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2009-07-15       Impact factor: 3.641

7.  A simple fragment of cyclic acyldepsipeptides is necessary and sufficient for ClpP activation and antibacterial activity.

Authors:  Daniel W Carney; Corey L Compton; Karl R Schmitz; Julia P Stevens; Robert T Sauer; Jason K Sello
Journal:  Chembiochem       Date:  2014-09-11       Impact factor: 3.164

8.  Targeting cancer-specific glycans by cyclic peptide lectinomimics.

Authors:  Maria C Rodriguez; Austin B Yongye; Mihael Cudic; Karina Martinez Mayorga; Enbo Liu; Barbara M Mueller; Jon Ainsley; Tatyana Karabencheva-Christova; Christo Z Christov; Mare Cudic; Predrag Cudic
Journal:  Amino Acids       Date:  2017-09-11       Impact factor: 3.520

9.  Construction of an expression vector for production and purification of human somatostatin in Escherichia coli.

Authors:  Sergi Maicas; Ismaïl Moukadiri; Almudena Nieto; Eulogio Valentín
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

10.  Solid-Phase Synthesis of Gly-Ψ[CH(CF3)NH]-Peptides.

Authors:  Clara Sgorbati; Eliana Lo Presti; Greta Bergamaschi; Monica Sani; Alessandro Volonterio
Journal:  J Org Chem       Date:  2021-06-03       Impact factor: 4.354
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.